- Report
- August 2023
- 145 Pages
Global
From €2738EUR$3,150USD£2,383GBP
- Report
- July 2023
- 145 Pages
Global
From €2738EUR$3,150USD£2,383GBP
- Report
- July 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- August 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- July 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- July 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- July 2024
- 100 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- July 2024
- 100 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- May 2023
- 450 Pages
Global
From €4345EUR$5,000USD£3,782GBP
- Report
- April 2023
- 399 Pages
Global
From €8256EUR$9,500USD£7,186GBP
- Report
- July 2024
- 130 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- July 2024
- 120 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2024
- 120 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2024
- 75 Pages
North America
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2024
- 110 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2024
- 120 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2024
- 131 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2024
- 75 Pages
Asia Pacific
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2024
- 135 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- April 2023
- 120 Pages
Global
From €4128EUR$4,750USD£3,593GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more